Related Experiment Video

Updated: Mar 10, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating

Q Li1, S Lu2, X Li3

  • 1Department of Urology, The First Affiliated Hospital, Zhengzhou University, Institute of Urology of Henan Province, No 1, Jianshe East Road, Zhengzhou, 450052, Henan, China. li_rechee@163.com.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|December 7, 2016
PubMed
Abstract

Insights

MicroRNA-33a (miR-33a) suppresses prostate cancer progression by downregulating Engrailed-2 (EN-2). This interaction inhibits tumor survival and metastasis, offering a potential therapeutic target for prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Engrailed-2 (EN-2) is a candidate oncogene in prostate cancer (PC).
  • The mechanism of EN-2 overexpression in PC is unknown, limiting therapeutic targeting.
  • Understanding EN-2 regulation is crucial for developing novel PC treatments.

Purpose of the Study:

  • To investigate the regulatory role of miR-33a on EN-2 expression in prostate cancer.
  • To explore the miR-33a/EN-2 signaling axis in prostate cancer survival and metastasis.
  • To identify potential therapeutic strategies targeting this pathway.

Main Methods:

  • Quantitative real-time PCR and Western blot to measure miR-33a and EN-2 expression.
  • Cell viability, migration, and invasion assays (MTT, TUNEL, Boyden chamber).
  • Luciferase reporter assay to confirm direct regulation of EN-2 by miR-33a.

Main Results:

  • miR-33a was upregulated, while EN-2 was downregulated in PC tissues and cell lines.
  • miR-33a overexpression suppressed PC cell survival and metastasis.
  • miR-33a directly targets EN-2 mRNA's 3'UTR, inhibiting its expression.
  • EN-2 overexpression reversed the anti-tumor effects of miR-33a.
  • miR-33a inhibited prostate tumor growth in xenograft models.

Conclusions:

  • The miR-33a/EN-2 interaction is integral to prostate cancer tumorigenesis.
  • EN-2 acts as a negative regulator in response to miR-33a.
  • This pathway represents a potential therapeutic target for prostate cancer.
Keywords:
Engrailed-2MiR-33aMigrationProstate cancer

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.1K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K